These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 30250166)

  • 1. Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs.
    Patti G; Cavallari I; Andreotti F; Calabrò P; Cirillo P; Denas G; Galli M; Golia E; Maddaloni E; Marcucci R; Parato VM; Pengo V; Prisco D; Ricottini E; Renda G; Santilli F; Simeone P; De Caterina R;
    Nat Rev Cardiol; 2019 Feb; 16(2):113-130. PubMed ID: 30250166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes: Prevalence, prognosis and management of a potent cardiovascular risk factor.
    Norhammar A; Mellbin L; Cosentino F
    Eur J Prev Cardiol; 2017 Jun; 24(3_suppl):52-60. PubMed ID: 28618910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombotic Therapy for Atherosclerotic Cardiovascular Disease Risk Mitigation in Patients With Coronary Artery Disease and Diabetes Mellitus.
    Capodanno D; Angiolillo DJ
    Circulation; 2020 Dec; 142(22):2172-2188. PubMed ID: 33253005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombotic therapy and revascularisation strategies in people with diabetes and coronary artery disease.
    Rocca B; Rubboli A; Zaccardi F
    Eur J Prev Cardiol; 2019 Dec; 26(2_suppl):92-105. PubMed ID: 31766921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombotic therapy in diabetes: which, when, and for how long?
    Ajjan RA; Kietsiriroje N; Badimon L; Vilahur G; Gorog DA; Angiolillo DJ; Russell DA; Rocca B; Storey RF
    Eur Heart J; 2021 Jun; 42(23):2235-2259. PubMed ID: 33764414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suboptimal control of lipid levels: results from the non-interventional Centralized Pan-Russian Survey of the Undertreatment of Hypercholesterolemia II (CEPHEUS II).
    Boytsov S; Logunova N; Khomitskaya Y;
    Cardiovasc Diabetol; 2017 Dec; 16(1):158. PubMed ID: 29246151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral antithrombotic therapy in atrial fibrillation associated with acute or chronic coronary artery disease.
    Cairns JA; McMurtry MS
    Can J Cardiol; 2013 Jul; 29(7 Suppl):S60-70. PubMed ID: 23790600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombotic therapy for secondary prevention of atherothrombotic events in cerebrovascular disease.
    Capodanno D; Alberts M; Angiolillo DJ
    Nat Rev Cardiol; 2016 Oct; 13(10):609-22. PubMed ID: 27489191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiplatelet and Antithrombotic Therapy in Type I Diabetes Mellitus: Update on Current Data.
    Maragkoudakis S; Katsi V; Melidonis A; Soulaidopoulos S; Kolovou GD; Papazafeiropoulou AK; Trikkalinou A; Toutouzas K; Tsioufis K
    Curr Diabetes Rev; 2022; 18(9):e030122199792. PubMed ID: 34979890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiplatelet and antithrombotic treatment for secondary prevention in ischaemic heart disease.
    Lettino M; Leonardi S; De Maria E; Halvorsen S
    Eur J Prev Cardiol; 2017 Jun; 24(3_suppl):61-70. PubMed ID: 28618904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Diabetic Status and Glycemic Control With Ischemic and Bleeding Outcomes in Patients With Stable Coronary Artery Disease: The 5-Year CORONOR Registry.
    Lemesle G; Meurice T; Tricot O; Lamblin N; Bauters C
    J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29728374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary and secondary prevention of cardiovascular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
    Vandvik PO; Lincoff AM; Gore JM; Gutterman DD; Sonnenberg FA; Alonso-Coello P; Akl EA; Lansberg MG; Guyatt GH; Spencer FA
    Chest; 2012 Feb; 141(2 Suppl):e637S-e668S. PubMed ID: 22315274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vorapaxar in patients with diabetes mellitus and previous myocardial infarction: findings from the thrombin receptor antagonist in secondary prevention of atherothrombotic ischemic events-TIMI 50 trial.
    Cavender MA; Scirica BM; Bonaca MP; Angiolillo DJ; Dalby AJ; Dellborg M; Morais J; Murphy SA; Ophuis TO; Tendera M; Braunwald E; Morrow DA
    Circulation; 2015 Mar; 131(12):1047-53. PubMed ID: 25681464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of antithrombotic therapy for secondary prevention in patients with stable atherosclerotic cardiovascular disease: Insights from the COordinated National Network to Engage Cardiologists in the antithrombotic Treatment of patients with CardioVascular Disease (CONNECT-CVD) study.
    Verma S; Goodman SG; Tan MK; Daneault B; Lubelsky BJ; Mansour S; Lam AS; Laflamme D; Tymchak WJ; Welsh RC; Rose RC; Chetty RM; Constance CM; Cieza T; Potter BJ; Hartleib MC; Khan R; Choi RF; Keeble W; Dery JP; Shukla D; Chua GL; Bainey KR
    Int J Clin Pract; 2021 Oct; 75(10):e14597. PubMed ID: 34228865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current state-of-the-art antiplatelet and anticoagulation therapy in diabetic patients with coronary artery disease.
    Nicolas J; Razuk V; Giustino G; Mehran R
    Future Cardiol; 2021 May; 17(3):521-534. PubMed ID: 33728965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Approaches to prevention of cardiovascular complications and events in diabetes mellitus.
    Coccheri S
    Drugs; 2007; 67(7):997-1026. PubMed ID: 17488145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is aspirin still the drug of choice for management of patients with peripheral arterial disease?
    Poredos P; Jezovnik MK
    Vasa; 2013 Mar; 42(2):88-95. PubMed ID: 23485835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic prevention of microvascular and macrovascular complications in diabetes mellitus: implications of the results of recent clinical trials in type 2 diabetes.
    Tandon N; Ali MK; Narayan KM
    Am J Cardiovasc Drugs; 2012 Feb; 12(1):7-22. PubMed ID: 22217193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiplatelet agents for the prevention of cardiovascular disease in diabetes mellitus.
    Colwell JA
    Am J Cardiovasc Drugs; 2004; 4(2):87-106. PubMed ID: 15049721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiplatelet strategy in primary and secondary prevention of cardiovascular disease in patients with type 2 diabetes mellitus: A perspective from the guideline appraisal.
    Liu M; Zhuang X; Chen X; Zhang S; Yang D; Zhong X; Xiong Z; Lin Y; Zhou H; Fan Y; Xie P; Huang Y; Wang L; Liao X
    J Diabetes Investig; 2021 Jan; 12(1):99-108. PubMed ID: 32543044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.